Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Applied Materials reported guidance for the second quarter that topped analyst expectations, prompting an 11.7% premarket jump in its shares. Management attributed the stronger outlook to accelerated industry investment in AI computing and rising demand for higher-performance, energy-efficient chips across logic, high-bandwidth memory and advanced …
Aluminum prices in London fell after reports that the U.S. administration is considering narrowing the scope of tariffs on certain metal products. The review, which could exempt some items and limit the expansion of tariffed goods, follows criticism that the duties are increasing costs for American consumers and businesses.
Norwegian Air Shuttle says it will not adopt Starlink inflight Wi-Fi at present, with CEO Geir Karlsen citing the airline's current paid-service arrangement and limitations on passenger charging and Boeing 737 certification. Major carriers are signing up to Starlink, but low-cost airlines that rely on ancillary revenue are less inclined to switch.
UBS adjusted its stance on Edison International (EIX), moving the stock from Buy to Neutral while increasing its price target. The broker pointed to recent share appreciation and a delayed legislative catalyst as reasons to temper near-term upside, even as the utility raises its dividend and pursues securitization to address wildfire-related costs.
UBS upgraded Xcel Energy (XEL) from Neutral to Buy and increased its price target to $89 from $81. The firm highlights a high-quality, fully regulated 9% EPS growth profile, rising data center load upside and a dividend track record, arguing these factors are not fully reflected in the current share price.
Bank of America has trimmed its expected March rate cut from 100 basis points to 50 basis points for the Central Bank of the Republic of Turkey, citing stronger-than-expected inflation readings and persistent CPI pressures. The bank now projects a March policy rate of 36.50%, a subsequent return to 100bp easing per meeting from April, and a year-en…
Raymond James upgraded Rayonier (NYSE: RYN) from Outperform to Strong Buy and increased its price target to $28 from $26 after the company completed its merger with PotlatchDeltic and delivered stronger-than-expected fourth-quarter results. The combined business controls more than 4.1 million acres of U.S. forestry, holds approximately $300 million…
Raymond James reduced its recommendation on IPG Photonics from Strong Buy to Outperform while boosting its price target to $180 from $97. The move follows strong fourth-quarter results that beat the firm's forecasts, rapid recent share appreciation and a sharp expansion in valuation multiples. The analyst highlighted growth drivers tied to CROSSBOW…
Nissan Motor's stock climbed nearly 9% after the company reported a swing to operating profit in the third quarter of its fiscal year ending March, posting a gross-margin beat despite revenue coming in below consensus. Macquarie upgraded the stock to Neutral and raised its price target after highlighting favourable foreign exchange, better-than-exp…
Shares of major European defense contractors rose on Friday after the UK unveiled an air-defense support package for Ukraine valued at over £500 million. The announcement includes direct missile deliveries, a £150 million contribution to NATO's PURL, a Belfast-made missile order, and future shipments of missiles and artillery rounds coordinated thr…
Piper Sandler launched coverage of Climb Bio (CLYM) with an Overweight rating and a $23 price objective, implying more than 330% upside from the stock's recent price. The firm emphasized clinical progress of budoprutug across three indications and the differentiated profile of CLYM116, while noting the company's balance sheet supports near-term dev…
Piper Sandler cut Hercules Capital Inc.'s rating from Overweight to Neutral and reduced its price target to $17.50 from $20.50 following the company's fourth-quarter results. The firm flagged Hercules' sizable software portfolio - roughly 35% of assets - as vulnerable to disruption from artificial intelligence, and trimmed near-term earnings foreca…
Chipotle (CMG) looks neither deeply undervalued nor richly expensive. The shares trade near $35.84 with a ~30-31x P/E and strong return metrics, but 2025 traffic weakness and margin trade-offs in 2026 mean upside depends on re-accelerating visits. A measured, mid-term buy-on-weakness approach with a defined stop and target captures upside if traffi…
ByteDance is reported to be in advanced negotiations to sell Shanghai Moonton Technology, the studio behind Mobile Legends: Bang Bang, to Saudi Arabia's Savvy Games Group for between $6 billion and $7 billion. Two people with direct knowledge of the discussions said the firms have agreed on broad terms and that the transaction could close as soon a…
Prysmian stock declined further Friday after media reports suggested Donald Trump might reverse some tariffs on aluminium and other metal goods. The news coincided with falls in aluminium futures on both the Shanghai Futures Exchange and the London Metal Exchange, prompting market moves across metal-related sectors.
Morgan Stanley downgraded Afya Ltd. (NASDAQ:AFYA) from Equalweight to Underweight and reduced its price target to $16.00 from $17.50. The firm flagged structural limits to student-seat growth in medicine, potential margin pressure as the company invests to scale adjacent businesses, regulatory constraints on intake and higher debt costs following a…
Rothschild Redburn upgraded Church & Dwight Co. Inc. (NYSE: CHD) from Sell to Neutral and increased its price target to $91 from $81, citing a more constructive view on the consumer goods company's near-term outlook. The change follows an evaluation of past pricing actions, brand performance across the Power Brands portfolio, and broader sales tren…
Global pharmaceutical companies are accelerating purchases of China-developed experimental medicines as they aim to cut costs ahead of looming patent expirations. Licensing deal values tied to the greater China region jumped to an unprecedented $137.7 billion last year, and industry advisers say the total could grow substantially again over the nex…
Barclays has reinstated coverage on Medtronic (MDT) with an Overweight rating and a $116 price target, reflecting about 15% upside from the stock's recent price. The bank highlights substantial growth potential in cardiac ablation systems and renal denervation technology, while valuation metrics and upcoming earnings could provide additional clarit…
SoftBank Group's stock plunged 8.9% after its December-quarter disclosure that ARM and OpenAI together comprise 65% of the company's net asset value (NAV). The conglomerate's NAV fell 1% from the end of September to February 11, with offsetting moves between ARM and additional OpenAI investment leaving the broader portfolio largely unchanged. The N…
Barclays downgraded Fortune Brands from Overweight to Equalweight and cut its price target to $55, citing guidance that fell well short of consensus and uncertainty about when margins will recover heading into 2026. The company also reported a Q4 2025 earnings and revenue miss, while investors weigh the potential impact of a new CEO against ongoing…
UBS lowered its price target on Pinterest Inc. to $26 from $40 while retaining a Buy rating after the social-image platform reported weaker-than-expected fourth-quarter results and issued softer guidance. The bank trimmed its 2026 revenue and adjusted EBITDA forecasts and cited persistent advertiser pressures and higher AI-related costs as factors …
Baird downgraded Pinterest Inc. (PINS) from Outperform to Neutral and trimmed its price target to $20 from $35, citing persistent headwinds among larger advertisers and recent company restructuring. The stock is trading near its 52-week low after a more than 52% decline over the past year. While user growth and engagement remain constructive and pr…
Neurocrine (NBIX) sold off after below-expectation Ingrezza guidance, but the underlying business remains healthy: Ingrezza grew to $2.51B, Q4 sales topped $805.5M, and the company generates meaningful free cash flow. This trade idea buys the weakness with a clear stop and a 180-trading-day target that prices in recovery plus pipeline upside.
Citizens has downgraded Upstart Holdings Inc. from Market Perform to Market Underperform and established a $20.00 price target. The research house says the move is largely valuation-driven following the release of three-year medium-term guidance, and it highlights both marketwide pressure on fintech lenders with private credit exposure and mixed fo…
